United States: FDA, ONC, And FCC Issue Draft Report On The Regulation And Oversight Of Health IT Technologies

On April 3, 2014, the Food and Drug Administration ("FDA") released its long-awaited report on a proposed framework for the regulation and oversight of health information technology ("health IT"). The report, developed in consultation with the Office of the National Coordinator for Health Information Technology ("ONC") and the Federal Communications Commission ("FCC"), fulfills a mandate in the Food and Drug Administration Safety and Innovation Act ("FDASIA") that required the agencies to produce a report on a "proposed strategy and recommendations" for the regulation of health IT. Public comments on the report are due July 7, 2014.

The report proposes a relatively "light touch" to the oversight of health IT, preferring ONC-coordinated activities and private sector capabilities to increased FDA regulation. Specifically, the report divides health IT into three categories based on the level of risk and functionality, in which only the highest risk category ("medical device health IT functions") will be the focus of FDA's regulatory oversight. This risk-based framework resembles the approach FDA took in its final guidance on mobile medical applications ("mobile apps"), as described in Ropes & Gray's recent alert.

One of the key areas addressed for the first time in the report is FDA's proposed approach to regulating clinical decision-making support ("CDS") tools. FDA proposes to exercise enforcement discretion not to regulate "most" CDS tools, even if they meet the definition of a medical device under the Food Drug & Cosmetic Act ("FDCA"). FDA also states, however, that it will regulate a "subset" of CDS tools as medical devices. The report does not define what will be included in that subset, instead stating that "FDA will work with federal and private stakeholders to clarify the types of medical device clinical decision support that should be the focus of FDA oversight." 

Categories of Health IT Functionalities

The report describes health IT as "a wide range of products, technologies, and services designed for use by health care entities, health care providers, and consumers, to electronically maintain, access, and exchange health information." Taking a risk-based, functional approach, the agencies propose classifying health IT products into the following three categories:

  1. Administrative Health IT Functionality. The report provides for "no additional oversight" with respect to this lowest-risk category. Examples of software functions that fall under this category include scheduling, billing and claims processing, and the determination of eligibility for health benefits.
  2. Health Management Health IT Functionality. For functions that fall under this second category, the report states that risk to patient safety is "generally low compared to the potential benefits." Examples of such functions include health information and medication management, electronic communication and access to clinical results, provider order entry, and "most" types of CDS. The agencies decided against proposing a formal regulatory approach to this category and chose instead to rely primarily on "ONC-coordinated activities and private sector capabilities" to ensure patient safety. This approach would apply even if the corresponding software meets the definition of a "device" under Section 201(h) of the FDCA. The report goes on to identify four key "priority areas" in its proposed collaborative approach to this second category: 

    • promoting the use of quality management principles, including a quality systems approach for the safe design, development, implementation, customization, and use of health IT;
    • identifying, developing, and adopting standards and best practices to deliver high quality health IT products and services;
    • leveraging conformity assessment tools such as product testing, certification, and accreditation; and
    • creating an environment of learning and continual improvement, including transparent reporting, aggregation, and analysis of safety issues with health IT products.

    The report seeks public comments on specific questions regarding each of these four areas. 
  3. Medical Device Health IT Functionality. FDA proposes to focus its oversight on this third, highest-risk category. Functions that fall under this category would include computer-aided detection or diagnosis, radiation treatment planning, and robotic surgical planning and control. As FDA already exercises its regulatory authority over software with these functionalities, the agencies propose no additional areas of oversight in the creation of this category.

Applying the Classification to CDS and Other Specific Functions 

The report provides only limited guidance as to how FDA is likely to view the proposed categories of health IT technology. Although the report provides a few specific examples of technologies that would fall within the proposed categories, developers and manufacturers of health IT technologies with functionalities that do not clearly fall under one of these examples will continue to have questions about the status of their products. This is particularly true in the case of CDS, a broad category of health IT that provides "knowledge and person-specific information, intelligently filtered or presented at appropriate times, to enhance health and health care." 

While the report states that "most" CDS functionalities would fall under the "health management health IT" category, others would be classified under the high-risk category and remain subject to FDA's continued focus and oversight. CDS functionalities that fall under this latter category include alerts for drug-drug interactions and drug-allergy contraindications, most drug dosing calculations, and software that suggests possible diagnoses based on patient-specific information retrieved from a patient's electronic health record. Examples of CDS software that will be regulated in the medical device category include computer-aided detection/diagnostic software, robotic surgical planning and control software, and electrocardiography analytical software. Further clarity with regard to such CDS software will be needed, and the report specifically seeks comments on the question of which types of CDS functionality should fall within the health management health IT category as opposed to the medical device category.

The report also cautions that categorizations may need to be adapted over time, that many systems (such as EHRs) have functionalities falling under multiple categories, and that many functionalities themselves, such as privacy and security, "cannot be placed in a single category." 

Health IT Safety Center 

Finally, the report provides that ONC is in the process of creating a public-private entity known as the Health IT Safety Center, an institution that will be charged with serving as a "trusted convener of stakeholders and as a forum for the exchange of ideas and information focused on promoting health IT as an integral part of patient safety." The Center is expected to launch later in 2014. 

Implications and Next Steps

The FDASIA health IT report provides important insight into the proposed regulatory approach that will affect software developers, other manufacturers and vendors of health IT systems, and health care providers that purchase, customize, and implement such systems. The report's focus on limited, risk-based regulation, and public-private cooperation, appears to be intended to address concerns about potential over-regulation by FDA. Some members of Congress who previously introduced legislation to curtail FDA's authority over health IT have already stated that the report, while it comports with FDASIA's mandate to adopt a risk-based approach, is insufficient because it relies on FDA "enforcement discretion" not to regulate lower-risk technologies, rather than setting clear limits in the law. These legislators can be expected to continue to push legislative solutions, which stakeholders should follow closely.

FDA has opened a docket and will be accepting comments on the proposed regulatory approach through July 7, and also is planning to hold a public meeting on the proposed strategy within 90 days of the report's release. After receiving public input and finalizing the proposed strategy and recommendations, the agencies plan to begin implementing the framework. Stakeholders should consider providing input on questions such as the regulation of CDS, the manner in which quality management principles will be applied to health IT products, how standards and conformity assessment tools will be identified and used, how reporting and aggregation of safety information relating to health IT will operate, and the roles and governance of the new Health IT Safety Center.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions